Home
Jeffrey Eisele, Chief Development Officer: Apellis Pharmaceuticals APLS Sell · Filed 25/01/14
Trade details
- Type
- Insider sale
- Amount
- $7,576.8
- Shares · price
- 264 sh · $28.70 a share
- Held after
- 56,881 sh
- Trade date
- 25/01/13
- Filed
- 25/01/14
- Days to filing
- 1 days
Sold 0.5% of holdings
- Share of holding sold
- 0.5%
Apellis Pharmaceuticals trades, last 26 weeks
What else happened in Apellis Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/12/14~25/02/12Jeffrey Eisele's recent trades
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$8,207
278 sh
$8,207
Filed 25/01/30
Traded 25/01/29
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$39.3K
1,291 sh
$39.3K
Filed 25/01/23
Traded 25/01/22
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$2,085
63 sh
$2,085
Filed 24/12/27
Traded 24/12/23
- Jeffrey Eisele
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 planApellis Pharmaceuticals
APLS
$63.6K
971 sh
$63.6K
Filed 24/01/31
Traded 24/01/30
- Jeffrey Eisele
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 planApellis Pharmaceuticals
APLS
$17.9K
279 sh
$17.9K
Filed 24/01/31
Traded 24/01/29